Skip to main content
Premium Trial:

Request an Annual Quote

Joel McComb, Gregory Heath, Stephen Becker, Beth Ladin

Premium
Joel McComb has become senior vice president and general manager of Illumina’s life sciences business unit, and Gregory Heath has become senior vice president and general manager of the company’s diagnostics business unit, Illumina said this week.
 
McComb joins Illumina from GE Healthcare, where he held a number of executive positions, most recently president of the interventional medicine business. Prior to this role, he was president of life sciences discovery systems, a business unit that was formed after GE acquired Amersham Biosciences. McComb holds a BS in genetics from the University of California, Davis, and an MBA from the Golden Gate University in San Francisco. In his new position at Illumina, he is responsible for managing all products and services related to the research market, namely the BeadArray, BeadXpress, and sequencing product lines.
 
Heath comes to Illumina from Roche Molecular Systems, where he held a number of senior executive positions, including head of clinical genomics, senior vice president of global product marketing, senior vice president of global marketing and business development, and, most recently, senior vice president of global business. Heath holds a PhD in experimental psychology from Virginia Commonwealth University, an MA in experimental psychology from Hollins College, and a BS in psychology from Illinois State University. At Illumina, he is responsible for managing the emerging diagnostics business, specifically overseeing the development of diagnostic content for the BeadXpress system, and ultimately for Illumina's sequencing products.
 

 
Stephen Becker has become vice president and commercial officer of RainDance Technologies, the company said this week. He joins RainDance from Agilent Technologies, where he was senior sales manager in the company's Americas field operations. Prior to that, he held several senior management positions at GE Healthcare, formerly Amersham Pharmacia Biotech. Becker has a bachelor's degree in biology from St. Mary's College of California.
 

 
Beth Ladin has become vice president of operations at NuGen Technologies, the company said this week. Prior to NuGen, she held several positions at Applied Biosystems, where she most recently was senior director of scientific operations for the applied markets division.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.